0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mefenamic Acid Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24B8059
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mefenamic Acid Market Insights Forecast to 2028
BUY CHAPTERS

Global Mefenamic Acid Market Research Report 2025

Code: QYRE-Auto-24B8059
Report
July 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mefenamic Acid Market Size

The global market for Mefenamic Acid was valued at US$ 2100 million in the year 2024 and is projected to reach a revised size of US$ 2845 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Mefenamic Acid Market

Mefenamic Acid Market

Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs, and is used to treat mild to moderate pain, including menstrual pain, and is sometimes used to prevent migraines associated with menstruation
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mefenamic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mefenamic Acid.
The Mefenamic Acid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mefenamic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mefenamic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mefenamic Acid Market Report

Report Metric Details
Report Name Mefenamic Acid Market
Accounted market size in year US$ 2100 million
Forecasted market size in 2031 US$ 2845 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Patent
  • Generic
Segment by Application
  • Hospital
  • Drug Store
  • On-line
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas, ABL Lifecare, Farmo Quimica, Apotex, Sanofi Aventis, Yung Sine, Streuli Pharma,, Mankind, Pfizer, Daiichi Sankyo, Chemidex Pharma, AA Pharma, Nisshin Pharmaceutical, Koa Isei, Teva, Wockhardt, Esteve
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mefenamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Mefenamic Acid Market growing?

Ans: The Mefenamic Acid Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Mefenamic Acid Market size in 2031?

Ans: The Mefenamic Acid Market size in 2031 will be US$ 2845 million.

Who are the main players in the Mefenamic Acid Market report?

Ans: The main players in the Mefenamic Acid Market are Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas, ABL Lifecare, Farmo Quimica, Apotex, Sanofi Aventis, Yung Sine, Streuli Pharma,, Mankind, Pfizer, Daiichi Sankyo, Chemidex Pharma, AA Pharma, Nisshin Pharmaceutical, Koa Isei, Teva, Wockhardt, Esteve

What are the Application segmentation covered in the Mefenamic Acid Market report?

Ans: The Applications covered in the Mefenamic Acid Market report are Hospital, Drug Store, On-line

What are the Type segmentation covered in the Mefenamic Acid Market report?

Ans: The Types covered in the Mefenamic Acid Market report are Patent, Generic

Recommended Reports

Analgesics Markets

API & Chemical Acids

Fibromyalgia & Migraine

1 Mefenamic Acid Market Overview
1.1 Product Definition
1.2 Mefenamic Acid by Type
1.2.1 Global Mefenamic Acid Market Value Comparison by Type (2024 VS 2031)
1.2.2 Patent
1.2.3 Generic
1.3 Mefenamic Acid by Application
1.3.1 Global Mefenamic Acid Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 On-line
1.4 Global Mefenamic Acid Market Size Estimates and Forecasts
1.4.1 Global Mefenamic Acid Revenue 2020-2031
1.4.2 Global Mefenamic Acid Sales 2020-2031
1.4.3 Global Mefenamic Acid Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mefenamic Acid Market Competition by Manufacturers
2.1 Global Mefenamic Acid Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mefenamic Acid Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mefenamic Acid Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mefenamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mefenamic Acid, Product Type & Application
2.7 Global Key Manufacturers of Mefenamic Acid, Date of Enter into This Industry
2.8 Global Mefenamic Acid Market Competitive Situation and Trends
2.8.1 Global Mefenamic Acid Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mefenamic Acid Players Market Share by Revenue
2.8.3 Global Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mefenamic Acid Market Scenario by Region
3.1 Global Mefenamic Acid Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mefenamic Acid Sales by Region: 2020-2031
3.2.1 Global Mefenamic Acid Sales by Region: 2020-2025
3.2.2 Global Mefenamic Acid Sales by Region: 2026-2031
3.3 Global Mefenamic Acid Revenue by Region: 2020-2031
3.3.1 Global Mefenamic Acid Revenue by Region: 2020-2025
3.3.2 Global Mefenamic Acid Revenue by Region: 2026-2031
3.4 North America Mefenamic Acid Market Facts & Figures by Country
3.4.1 North America Mefenamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mefenamic Acid Sales by Country (2020-2031)
3.4.3 North America Mefenamic Acid Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mefenamic Acid Market Facts & Figures by Country
3.5.1 Europe Mefenamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mefenamic Acid Sales by Country (2020-2031)
3.5.3 Europe Mefenamic Acid Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mefenamic Acid Market Facts & Figures by Region
3.6.1 Asia Pacific Mefenamic Acid Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mefenamic Acid Sales by Region (2020-2031)
3.6.3 Asia Pacific Mefenamic Acid Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mefenamic Acid Market Facts & Figures by Country
3.7.1 Latin America Mefenamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mefenamic Acid Sales by Country (2020-2031)
3.7.3 Latin America Mefenamic Acid Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mefenamic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Mefenamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mefenamic Acid Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mefenamic Acid Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mefenamic Acid Sales by Type (2020-2031)
4.1.1 Global Mefenamic Acid Sales by Type (2020-2025)
4.1.2 Global Mefenamic Acid Sales by Type (2026-2031)
4.1.3 Global Mefenamic Acid Sales Market Share by Type (2020-2031)
4.2 Global Mefenamic Acid Revenue by Type (2020-2031)
4.2.1 Global Mefenamic Acid Revenue by Type (2020-2025)
4.2.2 Global Mefenamic Acid Revenue by Type (2026-2031)
4.2.3 Global Mefenamic Acid Revenue Market Share by Type (2020-2031)
4.3 Global Mefenamic Acid Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mefenamic Acid Sales by Application (2020-2031)
5.1.1 Global Mefenamic Acid Sales by Application (2020-2025)
5.1.2 Global Mefenamic Acid Sales by Application (2026-2031)
5.1.3 Global Mefenamic Acid Sales Market Share by Application (2020-2031)
5.2 Global Mefenamic Acid Revenue by Application (2020-2031)
5.2.1 Global Mefenamic Acid Revenue by Application (2020-2025)
5.2.2 Global Mefenamic Acid Revenue by Application (2026-2031)
5.2.3 Global Mefenamic Acid Revenue Market Share by Application (2020-2031)
5.3 Global Mefenamic Acid Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shionogi Pharma
6.1.1 Shionogi Pharma Company Information
6.1.2 Shionogi Pharma Description and Business Overview
6.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shionogi Pharma Mefenamic Acid Product Portfolio
6.1.5 Shionogi Pharma Recent Developments/Updates
6.2 Solitaire Pharmacia
6.2.1 Solitaire Pharmacia Company Information
6.2.2 Solitaire Pharmacia Description and Business Overview
6.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
6.2.5 Solitaire Pharmacia Recent Developments/Updates
6.3 Shinto Organics
6.3.1 Shinto Organics Company Information
6.3.2 Shinto Organics Description and Business Overview
6.3.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shinto Organics Mefenamic Acid Product Portfolio
6.3.5 Shinto Organics Recent Developments/Updates
6.4 Captab
6.4.1 Captab Company Information
6.4.2 Captab Description and Business Overview
6.4.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Captab Mefenamic Acid Product Portfolio
6.4.5 Captab Recent Developments/Updates
6.5 EMS Pharma
6.5.1 EMS Pharma Company Information
6.5.2 EMS Pharma Description and Business Overview
6.5.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.5.4 EMS Pharma Mefenamic Acid Product Portfolio
6.5.5 EMS Pharma Recent Developments/Updates
6.6 Adelco
6.6.1 Adelco Company Information
6.6.2 Adelco Description and Business Overview
6.6.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Adelco Mefenamic Acid Product Portfolio
6.6.5 Adelco Recent Developments/Updates
6.7 Agron Remedies
6.7.1 Agron Remedies Company Information
6.7.2 Agron Remedies Description and Business Overview
6.7.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Agron Remedies Mefenamic Acid Product Portfolio
6.7.5 Agron Remedies Recent Developments/Updates
6.8 IASIS Pharmaceuticals Hellas
6.8.1 IASIS Pharmaceuticals Hellas Company Information
6.8.2 IASIS Pharmaceuticals Hellas Description and Business Overview
6.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.8.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
6.8.5 IASIS Pharmaceuticals Hellas Recent Developments/Updates
6.9 ABL Lifecare
6.9.1 ABL Lifecare Company Information
6.9.2 ABL Lifecare Description and Business Overview
6.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ABL Lifecare Mefenamic Acid Product Portfolio
6.9.5 ABL Lifecare Recent Developments/Updates
6.10 Farmo Quimica
6.10.1 Farmo Quimica Company Information
6.10.2 Farmo Quimica Description and Business Overview
6.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Farmo Quimica Mefenamic Acid Product Portfolio
6.10.5 Farmo Quimica Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Company Information
6.11.2 Apotex Description and Business Overview
6.11.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Apotex Mefenamic Acid Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Sanofi Aventis
6.12.1 Sanofi Aventis Company Information
6.12.2 Sanofi Aventis Description and Business Overview
6.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi Aventis Mefenamic Acid Product Portfolio
6.12.5 Sanofi Aventis Recent Developments/Updates
6.13 Yung Sine
6.13.1 Yung Sine Company Information
6.13.2 Yung Sine Description and Business Overview
6.13.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yung Sine Mefenamic Acid Product Portfolio
6.13.5 Yung Sine Recent Developments/Updates
6.14 Streuli Pharma,
6.14.1 Streuli Pharma, Company Information
6.14.2 Streuli Pharma, Description and Business Overview
6.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Streuli Pharma, Mefenamic Acid Product Portfolio
6.14.5 Streuli Pharma, Recent Developments/Updates
6.15 Mankind
6.15.1 Mankind Company Information
6.15.2 Mankind Description and Business Overview
6.15.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Mankind Mefenamic Acid Product Portfolio
6.15.5 Mankind Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Company Information
6.16.2 Pfizer Description and Business Overview
6.16.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Pfizer Mefenamic Acid Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Daiichi Sankyo
6.17.1 Daiichi Sankyo Company Information
6.17.2 Daiichi Sankyo Description and Business Overview
6.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
6.17.5 Daiichi Sankyo Recent Developments/Updates
6.18 Chemidex Pharma
6.18.1 Chemidex Pharma Company Information
6.18.2 Chemidex Pharma Description and Business Overview
6.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Chemidex Pharma Mefenamic Acid Product Portfolio
6.18.5 Chemidex Pharma Recent Developments/Updates
6.19 AA Pharma
6.19.1 AA Pharma Company Information
6.19.2 AA Pharma Description and Business Overview
6.19.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AA Pharma Mefenamic Acid Product Portfolio
6.19.5 AA Pharma Recent Developments/Updates
6.20 Nisshin Pharmaceutical
6.20.1 Nisshin Pharmaceutical Company Information
6.20.2 Nisshin Pharmaceutical Description and Business Overview
6.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
6.20.5 Nisshin Pharmaceutical Recent Developments/Updates
6.21 Koa Isei
6.21.1 Koa Isei Company Information
6.21.2 Koa Isei Description and Business Overview
6.21.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Koa Isei Mefenamic Acid Product Portfolio
6.21.5 Koa Isei Recent Developments/Updates
6.22 Teva
6.22.1 Teva Company Information
6.22.2 Teva Description and Business Overview
6.22.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Teva Mefenamic Acid Product Portfolio
6.22.5 Teva Recent Developments/Updates
6.23 Wockhardt
6.23.1 Wockhardt Company Information
6.23.2 Wockhardt Description and Business Overview
6.23.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Wockhardt Mefenamic Acid Product Portfolio
6.23.5 Wockhardt Recent Developments/Updates
6.24 Esteve
6.24.1 Esteve Company Information
6.24.2 Esteve Description and Business Overview
6.24.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Esteve Mefenamic Acid Product Portfolio
6.24.5 Esteve Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mefenamic Acid Industry Chain Analysis
7.2 Mefenamic Acid Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mefenamic Acid Production Mode & Process Analysis
7.4 Mefenamic Acid Sales and Marketing
7.4.1 Mefenamic Acid Sales Channels
7.4.2 Mefenamic Acid Distributors
7.5 Mefenamic Acid Customer Analysis
8 Mefenamic Acid Market Dynamics
8.1 Mefenamic Acid Industry Trends
8.2 Mefenamic Acid Market Drivers
8.3 Mefenamic Acid Market Challenges
8.4 Mefenamic Acid Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mefenamic Acid Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mefenamic Acid Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mefenamic Acid Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mefenamic Acid Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mefenamic Acid Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mefenamic Acid Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mefenamic Acid Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mefenamic Acid Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mefenamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mefenamic Acid, Product Type & Application
 Table 12. Global Key Manufacturers of Mefenamic Acid, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mefenamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefenamic Acid as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mefenamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mefenamic Acid Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mefenamic Acid Sales Market Share by Region (2020-2025)
 Table 19. Global Mefenamic Acid Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mefenamic Acid Sales Market Share by Region (2026-2031)
 Table 21. Global Mefenamic Acid Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mefenamic Acid Revenue Market Share by Region (2020-2025)
 Table 23. Global Mefenamic Acid Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mefenamic Acid Revenue Market Share by Region (2026-2031)
 Table 25. North America Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mefenamic Acid Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mefenamic Acid Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mefenamic Acid Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mefenamic Acid Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mefenamic Acid Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mefenamic Acid Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mefenamic Acid Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mefenamic Acid Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mefenamic Acid Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mefenamic Acid Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mefenamic Acid Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mefenamic Acid Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mefenamic Acid Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mefenamic Acid Sales (K Units) by Type (2020-2025)
 Table 51. Global Mefenamic Acid Sales (K Units) by Type (2026-2031)
 Table 52. Global Mefenamic Acid Sales Market Share by Type (2020-2025)
 Table 53. Global Mefenamic Acid Sales Market Share by Type (2026-2031)
 Table 54. Global Mefenamic Acid Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mefenamic Acid Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mefenamic Acid Revenue Market Share by Type (2020-2025)
 Table 57. Global Mefenamic Acid Revenue Market Share by Type (2026-2031)
 Table 58. Global Mefenamic Acid Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mefenamic Acid Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mefenamic Acid Sales (K Units) by Application (2020-2025)
 Table 61. Global Mefenamic Acid Sales (K Units) by Application (2026-2031)
 Table 62. Global Mefenamic Acid Sales Market Share by Application (2020-2025)
 Table 63. Global Mefenamic Acid Sales Market Share by Application (2026-2031)
 Table 64. Global Mefenamic Acid Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mefenamic Acid Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mefenamic Acid Revenue Market Share by Application (2020-2025)
 Table 67. Global Mefenamic Acid Revenue Market Share by Application (2026-2031)
 Table 68. Global Mefenamic Acid Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mefenamic Acid Price (US$/Unit) by Application (2026-2031)
 Table 70. Shionogi Pharma Company Information
 Table 71. Shionogi Pharma Description and Business Overview
 Table 72. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Shionogi Pharma Mefenamic Acid Product
 Table 74. Shionogi Pharma Recent Developments/Updates
 Table 75. Solitaire Pharmacia Company Information
 Table 76. Solitaire Pharmacia Description and Business Overview
 Table 77. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Solitaire Pharmacia Mefenamic Acid Product
 Table 79. Solitaire Pharmacia Recent Developments/Updates
 Table 80. Shinto Organics Company Information
 Table 81. Shinto Organics Description and Business Overview
 Table 82. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shinto Organics Mefenamic Acid Product
 Table 84. Shinto Organics Recent Developments/Updates
 Table 85. Captab Company Information
 Table 86. Captab Description and Business Overview
 Table 87. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Captab Mefenamic Acid Product
 Table 89. Captab Recent Developments/Updates
 Table 90. EMS Pharma Company Information
 Table 91. EMS Pharma Description and Business Overview
 Table 92. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. EMS Pharma Mefenamic Acid Product
 Table 94. EMS Pharma Recent Developments/Updates
 Table 95. Adelco Company Information
 Table 96. Adelco Description and Business Overview
 Table 97. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Adelco Mefenamic Acid Product
 Table 99. Adelco Recent Developments/Updates
 Table 100. Agron Remedies Company Information
 Table 101. Agron Remedies Description and Business Overview
 Table 102. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Agron Remedies Mefenamic Acid Product
 Table 104. Agron Remedies Recent Developments/Updates
 Table 105. IASIS Pharmaceuticals Hellas Company Information
 Table 106. IASIS Pharmaceuticals Hellas Description and Business Overview
 Table 107. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. IASIS Pharmaceuticals Hellas Mefenamic Acid Product
 Table 109. IASIS Pharmaceuticals Hellas Recent Developments/Updates
 Table 110. ABL Lifecare Company Information
 Table 111. ABL Lifecare Description and Business Overview
 Table 112. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. ABL Lifecare Mefenamic Acid Product
 Table 114. ABL Lifecare Recent Developments/Updates
 Table 115. Farmo Quimica Company Information
 Table 116. Farmo Quimica Description and Business Overview
 Table 117. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Farmo Quimica Mefenamic Acid Product
 Table 119. Farmo Quimica Recent Developments/Updates
 Table 120. Apotex Company Information
 Table 121. Apotex Description and Business Overview
 Table 122. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Apotex Mefenamic Acid Product
 Table 124. Apotex Recent Developments/Updates
 Table 125. Sanofi Aventis Company Information
 Table 126. Sanofi Aventis Description and Business Overview
 Table 127. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi Aventis Mefenamic Acid Product
 Table 129. Sanofi Aventis Recent Developments/Updates
 Table 130. Yung Sine Company Information
 Table 131. Yung Sine Description and Business Overview
 Table 132. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Yung Sine Mefenamic Acid Product
 Table 134. Yung Sine Recent Developments/Updates
 Table 135. Streuli Pharma, Company Information
 Table 136. Streuli Pharma, Description and Business Overview
 Table 137. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Streuli Pharma, Mefenamic Acid Product
 Table 139. Streuli Pharma, Recent Developments/Updates
 Table 140. Mankind Company Information
 Table 141. Mankind Description and Business Overview
 Table 142. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Mankind Mefenamic Acid Product
 Table 144. Mankind Recent Developments/Updates
 Table 145. Pfizer Company Information
 Table 146. Pfizer Description and Business Overview
 Table 147. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Pfizer Mefenamic Acid Product
 Table 149. Pfizer Recent Developments/Updates
 Table 150. Daiichi Sankyo Company Information
 Table 151. Daiichi Sankyo Description and Business Overview
 Table 152. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Daiichi Sankyo Mefenamic Acid Product
 Table 154. Daiichi Sankyo Recent Developments/Updates
 Table 155. Chemidex Pharma Company Information
 Table 156. Chemidex Pharma Description and Business Overview
 Table 157. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Chemidex Pharma Mefenamic Acid Product
 Table 159. Chemidex Pharma Recent Developments/Updates
 Table 160. AA Pharma Company Information
 Table 161. AA Pharma Description and Business Overview
 Table 162. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. AA Pharma Mefenamic Acid Product
 Table 164. AA Pharma Recent Developments/Updates
 Table 165. Nisshin Pharmaceutical Company Information
 Table 166. Nisshin Pharmaceutical Description and Business Overview
 Table 167. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Nisshin Pharmaceutical Mefenamic Acid Product
 Table 169. Nisshin Pharmaceutical Recent Developments/Updates
 Table 170. Koa Isei Company Information
 Table 171. Koa Isei Description and Business Overview
 Table 172. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Koa Isei Mefenamic Acid Product
 Table 174. Koa Isei Recent Developments/Updates
 Table 175. Teva Company Information
 Table 176. Teva Description and Business Overview
 Table 177. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Teva Mefenamic Acid Product
 Table 179. Teva Recent Developments/Updates
 Table 180. Wockhardt Company Information
 Table 181. Wockhardt Description and Business Overview
 Table 182. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Wockhardt Mefenamic Acid Product
 Table 184. Wockhardt Recent Developments/Updates
 Table 185. Esteve Company Information
 Table 186. Esteve Description and Business Overview
 Table 187. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Esteve Mefenamic Acid Product
 Table 189. Esteve Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Mefenamic Acid Distributors List
 Table 193. Mefenamic Acid Customers List
 Table 194. Mefenamic Acid Market Trends
 Table 195. Mefenamic Acid Market Drivers
 Table 196. Mefenamic Acid Market Challenges
 Table 197. Mefenamic Acid Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mefenamic Acid
 Figure 2. Global Mefenamic Acid Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mefenamic Acid Market Share by Type: 2024 & 2031
 Figure 4. Patent Product Picture
 Figure 5. Generic Product Picture
 Figure 6. Global Mefenamic Acid Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Mefenamic Acid Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. On-line
 Figure 11. Global Mefenamic Acid Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Mefenamic Acid Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Mefenamic Acid Sales (2020-2031) & (K Units)
 Figure 14. Global Mefenamic Acid Average Price (US$/Unit) & (2020-2031)
 Figure 15. Mefenamic Acid Report Years Considered
 Figure 16. Mefenamic Acid Sales Share by Manufacturers in 2024
 Figure 17. Global Mefenamic Acid Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Mefenamic Acid Players: Market Share by Revenue in Mefenamic Acid in 2024
 Figure 19. Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Mefenamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Mefenamic Acid Sales Market Share by Country (2020-2031)
 Figure 22. North America Mefenamic Acid Revenue Market Share by Country (2020-2031)
 Figure 23. United States Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Mefenamic Acid Sales Market Share by Country (2020-2031)
 Figure 26. Europe Mefenamic Acid Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Mefenamic Acid Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Mefenamic Acid Revenue Market Share by Region (2020-2031)
 Figure 34. China Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Mefenamic Acid Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Mefenamic Acid Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Mefenamic Acid Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Mefenamic Acid Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Mefenamic Acid by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Mefenamic Acid by Type (2020-2031)
 Figure 55. Global Mefenamic Acid Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Mefenamic Acid by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Mefenamic Acid by Application (2020-2031)
 Figure 58. Global Mefenamic Acid Price (US$/Unit) by Application (2020-2031)
 Figure 59. Mefenamic Acid Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String